Klinger H, Thompson G K, Yamamoto T. "Method for the Synthesis of Rivaroxaban Impurity 87" [P]. US Patent, US 10423233 B2, 2023-08-03.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质87 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 501, (7), 7900-7913.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质87 as an Impurity". Environ. Sci. Technol., 2017, 1373, (1), 5081-5103.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 87 Using HRMS and NMR". Anal. Methods, 2012, 2226, (1), 5936-5956.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 利伐沙班杂质87 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2012, 1814, (1), 5858-5863.